LIVZON PHARMA - Statement and Commitment of Independent Director Nominee of Livzon Pharmaceutical Group Co., Ltd. (Luo Huiyuan)
Overseas regulatory announcement
This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
The "Statement and Commitment of the Independent Director Nominee of Livzon Pharmaceutical Group Co., Ltd. (Luo Huiyuan)" published by Livzon Pharmaceutical Group Co., Ltd. on the website of the Shenzhen Stock Exchange is hereby provided for reference only.
By order of the board of directors
Livzon Pharmaceutical Group Co., Ltd.
LivzonPharmaceuticalGroupInc.*
company secretary
Liu Ning
China, Zhuhai
April 23, 2026
As of the date of this announcement, the company’s executive directors are Mr. Tang Yanggang (vice chairman); the company’s non-executive directors are Mr. Zhu Baoguo (chairman), Mr. Lin Nanqi and Mr. Qiu Qingfeng; the company’s employee directors are Ms. Ran Yongmei; and the company’s independent non-executive directors are Mr. Bai Hua, Mr. Luo Huiyuan, Ms. Cui Lijie and Ms. Wang Zhiyao.
*Identification only
Securities code: 000513, 01513 Securities abbreviation: Livzon Group, Livzon Pharmaceutical Announcement Number: 2026-31
Independent director nominee of Livzon Pharmaceutical Group Co., Ltd.
Statements and Commitments
The nominator, the Board of Directors of Livzon Pharmaceutical Group Co., Ltd., now makes a public statement on the nomination of Luo Huiyuan as an independent director candidate for the 12th Board of Directors of Livzon Pharmaceutical Group Co., Ltd. The nominee has agreed in writing to serve as an independent director candidate for the 12th Board of Directors of Livzon Pharmaceutical Group Co., Ltd. (see the independent director candidate statement). This nomination is made after fully understanding the nominee's occupation, education, professional title, detailed work experience, all part-time jobs, and whether there is any bad record such as major breach of trust. The nominator believes that the nominee meets the requirements for the qualifications and independence of independent director candidates in relevant laws, administrative regulations, departmental rules, normative documents and business rules of the Shenzhen Stock Exchange. He specifically declares and commits to the following matters:
- The nominee has passed the qualification review by the Nomination Committee of the 11th Board of Directors of Livzon Pharmaceutical Group Co., Ltd. or the special meeting of independent directors. There is no interest relationship or other close relationship between the nominee and the nominee that may affect the independent performance of duties.
√ Yes □ No
If not, please explain in detail:
- The nominee is not prohibited from serving as a director of the company under Article 178 of the Company Law of the People's Republic of China.
√ Yes □ No
If not, please explain in detail:
- The nominee meets the qualifications and conditions for serving as an independent director stipulated in the China Securities Regulatory Commission's "Administrative Measures for Independent Directors of Listed Companies" and the business rules of the Shenzhen Stock Exchange.
√ Yes □ No
If not, please explain in detail:
- The nominee meets the conditions for serving as an independent director as stipulated in the company's articles of association.
√ Yes □ No
If not, please explain in detail:
- The nominee has participated in training and obtained relevant training certification materials recognized by the stock exchange (if any).
√ Yes □ No
If not, please explain in detail:
- The nominee’s appointment as an independent director will not violate the relevant provisions of the Civil Servant Law of the People’s Republic of China.
√ Yes □ No
If not, please explain in detail:
- The nominee's appointment as an independent director will not violate the relevant provisions of the Central Commission for Discipline Inspection of the Communist Party of China's "Notice on Regulating Central Management Cadres to Resign from Public Office or Serve as Independent Directors and Independent Supervisors of Listed Companies and Fund Management Companies after Retirement".
√ Yes □ No
If not, please explain in detail:
- The appointment of the nominee as an independent director will not violate the relevant regulations of the Organization Department of the Central Committee of the Communist Party of China on the "Opinions on Further Regulating Part-time Work (Serving) of Party and Government Leading Cadres in Enterprises".
√ Yes □ No
If not, please explain in detail:
- The nominee’s appointment as an independent director will not violate the relevant regulations of the Central Commission for Discipline Inspection of the Communist Party of China, the Ministry of Education, and the Ministry of Supervision. √ Yes □ No
If not, please explain in detail:
- The nominee's appointment as an independent director will not violate the relevant provisions of the People's Bank of China's "Guidelines for the System of Independent Directors and External Supervisors of Joint-stock Commercial Banks".
√ Yes □ No
If not, please explain in detail:
- The nominee's appointment as an independent director will not violate the relevant provisions of the China Securities Regulatory Commission's "Measures for the Supervision and Administration of Directors, Supervisors, Senior Managers and Practitioners of Securities Fund Operating Institutions".
√ Yes □ No
If not, please explain in detail:
- The nominee's appointment as an independent director will not violate the relevant provisions of the "Measures for the Administration of Qualifications of Directors (Governors) and Senior Managers of Banking Financial Institutions". √ Yes □ No
If not, please explain in detail:
- The nominee's appointment as an independent director will not violate the relevant provisions of the "Regulations on the Qualifications of Directors, Supervisors and Senior Managers of Insurance Companies" and the "Regulations on the Management of Independent Directors of Insurance Institutions".
√ Yes □ No
If not, please explain in detail:
- The nominee’s appointment as an independent director will not violate other laws, administrative regulations, departmental rules, normative documents, Shenzhen Stock Exchange business rules and other relevant provisions on the qualifications of independent directors.
√ Yes □ No
If not, please explain in detail:
- The nominee has basic knowledge related to the operation of listed companies, is familiar with relevant laws, administrative regulations, departmental rules, normative documents and Shenzhen Stock Exchange business rules, and has more than five years of legal, economic, management, accounting, financial or other work experience necessary to perform the duties of an independent director.
√ Yes □ No
If not, please explain in detail:
- If nominated as an accounting professional, the nominee must have at least the qualification of a certified public accountant, or have a senior professional title, associate professor or above, or a doctoral degree in accounting, auditing or financial management, or have a senior professional title in economic management and have more than five years of full-time work experience in accounting, auditing or financial management professional positions.
□ Yes □ No √ Not applicable
If not, please explain in detail:
- Neither the nominee nor his immediate family members or major social relations hold positions in the company or its affiliated enterprises.
√ Yes □ No
If not, please explain in detail:
- The nominee and his immediate family members do not directly or indirectly hold the company
Shareholders with more than 1% of the issued shares are not natural person shareholders among the top ten shareholders of the listed company.
√ Yes □ No
If not, please explain in detail:
- The nominee and his immediate family members do not hold positions among shareholders who directly or indirectly hold more than 5% of the company’s issued shares, nor do they hold positions among the top five shareholders of the listed company. √ Yes □ No
If not, please explain in detail:
- The nominee and his immediate family members do not work in affiliated companies of the company’s controlling shareholder or actual controller.
√ Yes □ No
If not, please explain in detail:
- The nominee is not a person who provides financial, legal, consulting, sponsorship and other services to the company, its controlling shareholders, actual controllers or their respective subsidiaries, including but not limited to all project team members of the intermediaries providing services, reviewers at all levels, persons who signed the report, partners, directors, senior managers and principal persons in charge.
√ Yes □ No
If not, please explain in detail:
- The nominee does not have any major business dealings with the listed company, its controlling shareholders, actual controllers, or their respective subsidiaries, nor does he hold a position in any unit that has major business dealings with it, its controlling shareholders, or actual controllers.
√ Yes □ No
If not, please explain in detail:
- The nominee does not have any of the conditions specified in Items 17 to 22 in the last twelve months.
√ Yes □ No
If not, please explain in detail:
- The nominee is not a person who has been banned from the securities market by the China Securities Regulatory Commission and is prohibited from serving as a director or senior manager of a listed company, and the period has not yet expired.
√ Yes □ No
If not, please explain in detail:
- The nominee is not a person who has been publicly determined by the securities exchange to be unfit to serve as a director or senior manager of a listed company, and whose term has not yet expired.
√ Yes □ No
If not, please explain in detail:
- The nominee is not a person who has been criminally punished by judicial authorities or administratively punished by the China Securities Regulatory Commission due to securities and futures crimes in the past 36 months.
√ Yes □ No
If not, please explain in detail:
- The nominee is not a person who has been investigated by the China Securities Regulatory Commission or investigated by judicial authorities for being suspected of securities and futures illegal crimes, and no clear conclusion has been reached.
√ Yes □ No
If not, please explain in detail:
- The nominee has not been publicly condemned by the stock exchange or criticized three times or more by the stock exchange in the past 36 months.
√ Yes □ No
If not, please explain in detail:
- The nominee has no bad records such as major breach of trust. √ Yes □ No
If not, please explain in detail:
- The nominee is not an independent director who has been dismissed by the board of directors at the shareholders' meeting due to failure to attend two consecutive board meetings in person or to entrust other directors to attend the meeting for less than 12 months.
√ Yes □ No
If not, please explain in detail:
- Including the companies nominated this time, the number of domestic listed companies for which the nominee serves as independent director shall not exceed three.
√ Yes □ No
If not, please explain in detail:
- The nominee has served as an independent director in the company for no more than six consecutive years. √ Yes □ No
If not, please explain in detail:
The nominator solemnly promises:
The nominator guarantees that the above statement is true, accurate and complete, and contains no false records, misleading statements or major omissions; otherwise, the nominator is willing to bear the legal liability arising therefrom and accept the self-regulatory measures or disciplinary sanctions of the Shenzhen Stock Exchange.
The nominator authorizes the secretary of the company's board of directors to enter and submit the contents of this statement to the Shenzhen Stock Exchange through the business area of the Shenzhen Stock Exchange or to announce it to the public. The above actions of the secretary of the board of directors shall be deemed to be the actions of the nominator, and the nominator shall bear the corresponding legal liability.
During the period when the nominee serves as an independent director, if any circumstances arise that do not meet the requirements for independence and the qualifications for serving as an independent director, the nominee will promptly report to the company's board of directors and urge the nominee to immediately resign as an independent director.
Nominator: Board of Directors of Livzon Pharmaceutical Group Co., Ltd.
April 23, 2026